DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Medtech (296)

Varicose Vein Treatment Devices | Medtech 360 | Market Insights | Europe

Varicose Vein Treatment Devices | Medtech 360 | Market Insights | Europe

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

The European varicose vein treatment device market will be characterized by shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which will compete with surgical stripping procedures through 2027

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for varicose vein treatment devices in Europe across a 10-year period.


Endovenous ablation varicose vein treatment options are becoming increasingly accessible in Europe.

What is the current reimbursement situation for ELA and ERFA procedures?

How will the recently approved MOCA and cyanoacrylate adhesive devices drive adoption?

Sclerotherapy use will expand through 2027.

What are some of the approved sclerosing agents on the market? 

How will the introduction of polidocanol microfoam affect the market?

Surgical stripping remains the common procedure utilized in the treatment of varicose veins in some countries.

Why do these invasive procedures continue to be popular in some countries?

How will the increasing availability of minimally invasive treatment options impact surgical vein stripping procedure  volumes?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Varicose Vein Treatment Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Market Developments
      • Competitive Factors and Strategies
        • Reimbursement
        • First-Mover Advantage
        • Distribution and Sales Network
        • Physician Training and Marketing
        • Clinical Data
        • Product Improvements and Innovations
        • Regulatory Environment
        • Pricing Strategies and Purchasing Options
        • Product Portfolio Managment
        • Domestic Competitors
        • Sites of Service
    • Endovenous Ablation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Thermal Devices
        • Nonthermal Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Product Improvements and Innovations
    • Surgical Stripping Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Phlebectomy Procedures
      • Procedure Highlights
      • Procedure Definitions
      • Procedure Forecast Data
      • Competitive Highlights
      • List of Competitors
      • Competitive Factors and Strategies
    • Sclerotherapy Agent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Primary and Adjunctive Treatments
        • Spider Vein Treatments
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Already a Client? Log in to access this report.

  • Pub Date: November 2018
  • Author(s): Shruthi Narendranath, MSc
  • Shruthi Narendranath is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in heart valve and periphral vascular device markets. Shruthi holds a Master's degree in Bioinformatics from Cardiff University.  

Purchase Report

Recent reports:
You may also be interested in: